OPRX OptimizeRx Corp

OptimizeRx to Participate in Upcoming Investor Conferences

OptimizeRx to Participate in Upcoming Investor Conferences

WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:



  • B. Riley Securities 25th Annual Investor Conference, Marina del Rey, May 21 – 22, 2025
  • Stifel 2025 Boston Cross Sector 1x1 Conference, Boston, June 3 – 4, 2025
  • 45th Annual William Blair Growth Stock Conference, Chicago, June 3 – 5, 2025
  • The Citizens Medical Devices and Healthcare Services Forum, Boston, June 17, 2025



B. Riley Securities 25th Annual Investor Conference
Date: Thursday, May 22, 2025
Format:1x1 Meetings & Fireside Chat
Location:The Ritz-Carlton, Marina del Rey
  
Stifel 2025 Boston Cross Sector 1x1 Conference
Date: Tuesday, June 3, 2025
Format:1x1 Meetings
Location:InterContinental Boston
  
45th Annual William Blair Growth Stock Conference
Date: Thursday, June 5, 2025
Format:1x1 Meetings
Location:Loews Chicago Hotel
  
The Citizens Medical Devices and Healthcare Services Forum
Date: Tuesday, June 17, 2025
Format:1x1 Meetings
Location:Boston Harbor Hotel



To request a meeting or for more details about the conferences please reach out to your institutional contact.

About OptimizeRx

OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.

Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.

OptimizeRx Contact

Andy D’Silva, SVP Corporate Finance

Investor Relations Contact

Steven Halper

LifeSci Advisors, LLC



EN
16/05/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OptimizeRx Corp

 PRESS RELEASE

OptimizeRx to Participate in Upcoming Investor Conferences

OptimizeRx to Participate in Upcoming Investor Conferences WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences: B. Riley Securities 25th Annual Investor Conference, Marina del Rey, May 21 – 22, 2025Stifel 2025 Boston Cross Sector 1x1 Conference, Boston, June 3 – 4, 202545th Annual William Blair Growth ...

 PRESS RELEASE

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fi...

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance Q1 revenue of $21.9 million, increasing 11% year-over-yearQ1 gross profit increased 9% year-over-year to $13.3 millionIncreases full year 2025 guidance to a revenue range between $101 million and $106 million and adjusted EBITDA range between $13 million and $15 million WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HC...

 PRESS RELEASE

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) R...

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environmental, Social and Governance (ESG) report for 2025. As a company focused on optimizing meaningful engagement opportunities at critical junctures of the healthcare journey, we remain dedicated to aligning our mission with our responsibilities as a corporate ci...

 PRESS RELEASE

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, a...

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Monday, May 12, 2025, at 4:30 p.m. Eastern Time to discuss its results for the first quarter period ended March 31, 2025. The financial results will be issued in a press release prior to the call. OptimizeRx management will host the call, follow...

 PRESS RELEASE

OptimizeRx Corporation Announces Plan for Additional Board of Director...

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that, as part of OptimizeRx’s ongoing process to refresh and expand its board of directors (the “Board”), it intends to appoint a new independent director to its Board of Directors during the second half of this year.  With the appointment of a new independent ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch